Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
Clinical trial NCT06781983 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06781983
- Sponsor
- Innate Pharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-24
- Primary completion
- 2028-04-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.